Showing results (1-10 of 389) with videos related to
Sort By:
Pageof 39
Current Opinion in Infectious Diseases|September 10, 2009
Clostridium difficile: controversies and approaches to managementMartijn P Bauer, Jaap T van Dissel, Ed J KuijperNederlands Tijdschrift Voor Geneeskunde|December 2, 2010
[The rise of resistant gram-negative bacteria]Ed J Kuijper, Jaap T van DisselInternational Journal of Antimicrobial Agents|March 24, 2009
Alternative strategies for Clostridium difficile infectionMartijn P Bauer, Jaap T van DisselCurrent Opinion in Infectious Diseases|July 5, 2007
Clostridium difficile: changing epidemiology and new treatment optionsEd J Kuijper, Jaap T van Dissel, Mark H WilcoxInfectious Disease Clinics of North America|January 14, 2015
Potential sources of Clostridium difficile in human infectionMartijn P Bauer, Ed J KuijperNederlands Tijdschrift Voor Geneeskunde|September 10, 2011
[Outbreak of Shiga toxin-producing Escherichia coli and haemolytic uraemic syndrome]Ed J Kuijper, Aura Timen, Eelco Franz, et al.Lancet (London, England)|November 19, 2010
Clostridium difficile infection in Europe: a hospital-based surveyMartijn P Bauer, Daan W Notermans, Birgit H B van Benthem, et al.Journal of Medical Microbiology|January 28, 2005
Bovine antibody-enriched whey to aid in the prevention of a relapse of Clostridium difficile-associated diarrhoea: preclinical and preliminary clinical dataJaap T van Dissel, Nanda de Groot, Charles Mh Hensgens, et al.The Journal of Antimicrobial Chemotherapy|February 20, 2013
Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implicationsSylvia B Debast, Martijn P Bauer, Ingrid M J G Sanders, et al.Antimicrobial Agents and Chemotherapy|October 19, 2011
Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literatureSimone M T Camps, Jan W M van der Linden, Yi Li, et al.Pageof 39